199 related articles for article (PubMed ID: 22708486)
1. Fragile X mental retardation protein: past, present and future.
Kim M; Ceman S
Curr Protein Pept Sci; 2012 Jun; 13(4):358-71. PubMed ID: 22708486
[TBL] [Abstract][Full Text] [Related]
2. microRNAs and Fragile X Syndrome.
Lin SL
Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses.
Antar LN; Afroz R; Dictenberg JB; Carroll RC; Bassell GJ
J Neurosci; 2004 Mar; 24(11):2648-55. PubMed ID: 15028757
[TBL] [Abstract][Full Text] [Related]
4. Fragile X syndrome: From protein function to therapy.
Bagni C; Oostra BA
Am J Med Genet A; 2013 Nov; 161A(11):2809-21. PubMed ID: 24115651
[TBL] [Abstract][Full Text] [Related]
5. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.
Bassell GJ; Warren ST
Neuron; 2008 Oct; 60(2):201-14. PubMed ID: 18957214
[TBL] [Abstract][Full Text] [Related]
6. Post-translational modifications of the Fragile X Mental Retardation Protein in neuronal function and dysfunction.
Prieto M; Folci A; Martin S
Mol Psychiatry; 2020 Aug; 25(8):1688-1703. PubMed ID: 31822816
[TBL] [Abstract][Full Text] [Related]
7. The molecular biology of FMRP: new insights into fragile X syndrome.
Richter JD; Zhao X
Nat Rev Neurosci; 2021 Apr; 22(4):209-222. PubMed ID: 33608673
[TBL] [Abstract][Full Text] [Related]
8. Fragile X Mental Retardation Protein and Dendritic Local Translation of the Alpha Subunit of the Calcium/Calmodulin-Dependent Kinase II Messenger RNA Are Required for the Structural Plasticity Underlying Olfactory Learning.
Daroles L; Gribaudo S; Doulazmi M; Scotto-Lomassese S; Dubacq C; Mandairon N; Greer CA; Didier A; Trembleau A; Caillé I
Biol Psychiatry; 2016 Jul; 80(2):149-159. PubMed ID: 26372002
[TBL] [Abstract][Full Text] [Related]
9. Fragile X syndrome: from molecular genetics to therapy.
D'Hulst C; Kooy RF
J Med Genet; 2009 Sep; 46(9):577-84. PubMed ID: 19724010
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotide rescue of CGG expansion-dependent
Shah S; Sharp KJ; Raju Ponny S; Lee J; Watts JK; Berry-Kravis E; Richter JD
Proc Natl Acad Sci U S A; 2023 Jul; 120(27):e2302534120. PubMed ID: 37364131
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of fragile X syndrome: a twenty-year perspective.
Santoro MR; Bray SM; Warren ST
Annu Rev Pathol; 2012; 7():219-45. PubMed ID: 22017584
[TBL] [Abstract][Full Text] [Related]
12. [Chromatin changes caused by CGG repeat expansion in fmr1 gene].
Yudkin DV; Lemskaya NA; Grischenko IV; Dolskiy AA
Mol Biol (Mosk); 2015; 49(2):205-11. PubMed ID: 26065250
[TBL] [Abstract][Full Text] [Related]
13. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.
De Rubeis S; Fernández E; Buzzi A; Di Marino D; Bagni C
Adv Exp Med Biol; 2012; 970():517-51. PubMed ID: 22351071
[TBL] [Abstract][Full Text] [Related]
14. A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome.
Dictenberg JB; Swanger SA; Antar LN; Singer RH; Bassell GJ
Dev Cell; 2008 Jun; 14(6):926-39. PubMed ID: 18539120
[TBL] [Abstract][Full Text] [Related]
15. Regional FMRP deficits and large repeat expansions into the full mutation range in a new Fragile X premutation mouse model.
Entezam A; Biacsi R; Orrison B; Saha T; Hoffman GE; Grabczyk E; Nussbaum RL; Usdin K
Gene; 2007 Jun; 395(1-2):125-34. PubMed ID: 17442505
[TBL] [Abstract][Full Text] [Related]
16. Biophysical characterization of G-quadruplex forming FMR1 mRNA and of its interactions with different fragile X mental retardation protein isoforms.
Blice-Baum AC; Mihailescu MR
RNA; 2014 Jan; 20(1):103-14. PubMed ID: 24249225
[TBL] [Abstract][Full Text] [Related]
17. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency.
Buijsen RA; Visser JA; Kramer P; Severijnen EA; Gearing M; Charlet-Berguerand N; Sherman SL; Berman RF; Willemsen R; Hukema RK
Hum Reprod; 2016 Jan; 31(1):158-68. PubMed ID: 26537920
[TBL] [Abstract][Full Text] [Related]
18. Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons.
Tabet R; Moutin E; Becker JA; Heintz D; Fouillen L; Flatter E; Krężel W; Alunni V; Koebel P; Dembélé D; Tassone F; Bardoni B; Mandel JL; Vitale N; Muller D; Le Merrer J; Moine H
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3619-28. PubMed ID: 27233938
[TBL] [Abstract][Full Text] [Related]
19. Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations?
Salat U; Bardoni B; Wöhrle D; Steinbach P
J Med Genet; 2000 Nov; 37(11):842-50. PubMed ID: 11073538
[TBL] [Abstract][Full Text] [Related]
20. Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes.
Feng Y; Gutekunst CA; Eberhart DE; Yi H; Warren ST; Hersch SM
J Neurosci; 1997 Mar; 17(5):1539-47. PubMed ID: 9030614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
